SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jacob D. Jones, Charles Jacobson, Martina Murphy, Catherine Price, Michael S. Okun, Dawn Bowers, Influence of Hypertension on Neurocognitive Domains in Nondemented Parkinson’s Disease Patients, Parkinson's Disease, 2014, 2014, 1

    CrossRef

  2. 2
    Federica Agosta, Elisa Canu, Elka Stefanova, Lidia Sarro, Aleksandra Tomić, Vladana Špica, Giancarlo Comi, Vladimir S. Kostić, Massimo Filippi, Mild cognitive impairment in Parkinson's disease is associated with a distributed pattern of brain white matter damage, Human Brain Mapping, 2014, 35, 5
  3. 3
    Manju Liu, Haibo Xu, Yuhui Wang, Yi Zhong, Shuang Xia, David Utriainen, Tao Wang, E. Mark Haacke, Patterns of chronic venous insufficiency in the dural sinuses and extracranial draining veins and their relationship with white matter hyperintensities for patients with Parkinson's disease, Journal of Vascular Surgery, 2014,

    CrossRef

  4. 4
    A. A. Assareh, K. A. Mather, J. D. Crawford, W. Wen, K. J. Anstey, S. Easteal, X. Tan, H. A. Mack, J. B. J. Kwok, P. R. Schofield, P. S. Sachdev, Renin-Angiotensin System Genetic Polymorphisms and Brain White Matter Lesions in Older Australians, American Journal of Hypertension, 2014, 27, 9, 1191

    CrossRef

  5. 5
    Nagaendran Kandiah, Elijah Mak, Amanda Ng, Shan Huang, Wing Lok Au, Yih Yian Sitoh, Louis C.S. Tan, Cerebral white matter hyperintensity in Parkinson's disease: A major risk factor for mild cognitive impairment, Parkinsonism & Related Disorders, 2013, 19, 7, 680

    CrossRef

  6. 6
    Mona K. Beyer, Guido Alves, Kristy S. Hwang, Sona Babakchanian, Kolbjorn S. Bronnick, Yi-Yu Chou, Turi O. Dalaker, Martin W. Kurz, Jan P. Larsen, Johanne H. Somme, Paul M. Thompson, Ole-Bjørn Tysnes, Liana G. Apostolova, Cerebrospinal fluid Aβ levels correlate with structural brain changes in Parkinson's disease, Movement Disorders, 2013, 28, 3
  7. 7
    J. B. Toledo, S. E. Arnold, K. Raible, J. Brettschneider, S. X. Xie, M. Grossman, S. E. Monsell, W. A. Kukull, J. Q. Trojanowski, Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre, Brain, 2013, 136, 9, 2697

    CrossRef

  8. 8
    Gordon W. Duncan, Michael J. Firbank, John T. O'Brien, David J. Burn, Magnetic resonance imaging: A biomarker for cognitive impairment in Parkinson's disease?, Movement Disorders, 2013, 28, 4
  9. 9
    In-Uk Song, Young-Do Kim, Hyun-Ji Cho, Sung-Woo Chung, The effects of silent cerebral ischemic lesions on the prognosis of idiopathic Parkinson's disease, Parkinsonism & Related Disorders, 2013, 19, 8, 761

    CrossRef

  10. 10
    A. Fanciulli, S. Strano, C. Colosimo, C. Caltagirone, G. Spalletta, F. E. Pontieri, The potential prognostic role of cardiovascular autonomic failure in α-synucleinopathies, European Journal of Neurology, 2013, 20, 2
  11. 11
    Myria Petrou, Vikas Kotagal, Nicolaas I Bohnen, An update on brain imaging in parkinsonian dementia, Imaging in Medicine, 2012, 4, 2, 201

    CrossRef

  12. 12
    Takaaki Hattori, Satoshi Orimo, Shigeki Aoki, Kenji Ito, Osamu Abe, Atsushi Amano, Ryo Sato, Kasumi Sakai, Hidehiro Mizusawa, Cognitive status correlates with white matter alteration in Parkinson's disease, Human Brain Mapping, 2012, 33, 3
  13. 13
    J.D. Jones, I. Malaty, C.C. Price, M.S. Okun, D. Bowers, Health comorbidities and cognition in 1948 patients with idiopathic Parkinson's disease, Parkinsonism & Related Disorders, 2012, 18, 10, 1073

    CrossRef

  14. 14
    Ivan Rektor, David Goldemund, Petr Bednařík, Kateřina Sheardová, Zuzana Michálková, Sabina Telecká, Michal Dufek, Irena Rektorová, Impairment of brain vessels may contribute to mortality in patients with Parkinson's disease, Movement Disorders, 2012, 27, 9
  15. 15
    James F. Morley, John E. Duda, Parkinson's disease and the risk of cerebrovascular pathology, Movement Disorders, 2012, 27, 12
  16. 16
    Raymond S. Schwartz, Glenda M. Halliday, Dennis J. Cordato, Jillian J. Kril, Small-vessel disease in patients with Parkinson's disease: A clinicopathological study, Movement Disorders, 2012, 27, 12
  17. 17
    R. González-Redondo, J. Toledo, P. Clavero, I. Lamet, D. García-García, R. García-Eulate, P. Martínez-Lage, M. C. Rodríguez-Oroz, The impact of silent vascular brain burden in cognitive impairment in Parkinson’s disease, European Journal of Neurology, 2012, 19, 8
  18. 18
    Igor N. Petrovic, Elka Stefanova, Dusko Kozic, Robert Semnic, Vladana Markovic, Natasa T. Daragasevic, Vladimir S. Kostic, White matter lesions and depression in patients with Parkinson's disease, Journal of the Neurological Sciences, 2012, 322, 1-2, 132

    CrossRef

  19. 19
    N. Tambasco, V. Belcastro, P. Sarchielli, P. Floridi, L. Pierguidi, C. Menichetti, A. Castrioto, P. Chiarini, L. Parnetti, P. Eusebi, P. Calabresi, A. Rossi, A magnetization transfer study of mild and advanced Parkinson’s disease, European Journal of Neurology, 2011, 18, 3
  20. 20
    Flavio Nobili, Dario Arnaldi, Claudio Campus, Michela Ferrara, Fabrizio De Carli, Andrea Brugnolo, Barbara Dessi, Nicola Girtler, Silvia Morbelli, Giovanni Abruzzese, Gianmario Sambuceti, Guido Rodriguez, Brain perfusion correlates of cognitive and nigrostriatal functions in de novo Parkinson’s disease, European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38, 12, 2209

    CrossRef

  21. 21
    Paolo Barone, Dag Aarsland, David Burn, Murat Emre, Jaime Kulisevsky, Daniel Weintraub, Cognitive impairment in nondemented Parkinson's disease, Movement Disorders, 2011, 26, 14
  22. 22
    P. Martinez-Martin, C. Falup-Pecurariu, C. Rodriguez-Blazquez, M. Serrano-Dueñas, F.J. Carod Artal, J.M. Rojo Abuin, D. Aarsland, Dementia associated with Parkinson’s disease: Applying the Movement Disorder Society Task Force criteria, Parkinsonism & Related Disorders, 2011, 17, 8, 621

    CrossRef

  23. 23
    M. Patel, C. Coutinho, H.C.A. Emsley, Prevalence of radiological and clinical cerebrovascular disease in idiopathic Parkinson's disease, Clinical Neurology and Neurosurgery, 2011, 113, 10, 830

    CrossRef

  24. 24
    Arezoo Assareh, Karen A. Mather, Peter R. Schofield, John B.J. Kwok, Perminder S. Sachdev, The Genetics of White Matter Lesions, CNS Neuroscience & Therapeutics, 2011, 17, 5
  25. 25
    Nicolaas I. Bohnen, Roger L. Albin, White matter lesions in Parkinson disease, Nature Reviews Neurology, 2011, 7, 4, 229

    CrossRef

  26. 26
    Sun-Ah Choi, Virgilio Gerald H. Evidente, John N Caviness, Comparing Cerebral White Matter Lesion Burdens between Parkinson’s Disease with and without Dementia, Journal of Movement Disorders, 2010, 3, 1, 6

    CrossRef

  27. 27
    Seung-Jae Lee, Joong-Seok Kim, Ji-Yeon Yoo, In-Uk Song, Bum-Soo Kim, So-Lyung Jung, Dong-Won Yang, Yeong-In Kim, Du-Shin Jeong, Kwang-Soo Lee, Influence of White Matter Hyperintensities on the Cognition of Patients With Parkinson Disease, Alzheimer Disease & Associated Disorders, 2010, 1

    CrossRef

  28. 28
    Dag Aarsland, Martin Wilhelm Kurz, The Epidemiology of Dementia Associated with Parkinson's Disease, Brain Pathology, 2010, 20, 3
  29. 29
    Turi O. Dalaker, Jan P. Larsen, Niels Bergsland, Mona K. Beyer, Guido Alves, Michael G. Dwyer, Ole-Bjorn Tysnes, Ralph H.B. Benedict, Arpad Kelemen, Kolbjorn Bronnick, Robert Zivadinov, Brain atrophy and white matter hyperintensities in early Parkinson's disease, Movement Disorders, 2009, 24, 15
  30. 30
    Oraporn Sitburana, William G. Ondo, Brain magnetic resonance imaging (MRI) in parkinsonian disorders, Parkinsonism & Related Disorders, 2009, 15, 3, 165

    CrossRef

  31. 31
    E. Harboe, M. K. Beyer, O. J. Greve, L. G. Gøransson, A. B. Tjensvoll, J. T. Kvaløy, R. Omdal, Cerebral white matter hyperintensities are not increased in patients with primary Sjögren’s syndrome, European Journal of Neurology, 2009, 16, 5
  32. 32
    Wandana Nanhoe-Mahabier, Karlijn F. de Laat, Jasper E. Visser, Jan Zijlmans, Frank-Erik de Leeuw, Bastiaan R. Bloem, Parkinson disease and comorbid cerebrovascular disease, Nature Reviews Neurology, 2009, 5, 10, 533

    CrossRef

  33. 33
    Seung-Jae Lee, Joong-Seok Kim, Kwang-Soo Lee, Jae-Young An, Woojun Kim, Yeong-In Kim, Bum-Soo Kim, So-Lyung Jung, The severity of leukoaraiosis correlates with the clinical phenotype of Parkinson’s disease, Archives of Gerontology and Geriatrics, 2009, 49, 2, 255

    CrossRef

  34. 34
    Turi O. Dalaker, Jan P. Larsen, Michael G. Dwyer, Dag Aarsland, Mona K. Beyer, Guido Alves, Kolbjorn Bronnick, Ole-Bjorn Tysnes, Robert Zivadinov, White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease, NeuroImage, 2009, 47, 4, 2083

    CrossRef

  35. 35
    Tae Sung Lim, Phil Hyu Lee, Ho Sung Kim, Seok Woo Yong, White matter hyperintensities in patients with multiple system atrophy, Journal of Neurology, 2009, 256, 10, 1663

    CrossRef

  36. 36
    Wei Wen, Perminder S. Sachdev, Jason J. Li, Xiaohua Chen, Kaarin J. Anstey, White matter hyperintensities in the forties: Their prevalence and topography in an epidemiological sample aged 44–48, Human Brain Mapping, 2009, 30, 4
  37. 37
    Christopher G. Goetz, Murat Emre, Bruno Dubois, Parkinson's disease dementia: Definitions, guidelines, and research perspectives in diagnosis, Annals of Neurology, 2008, 64, S2
  38. 38
    S MILLS, J CAIN, N PURANDARE, A JACKSON, Biomarkers of cerebrovascular disease in dementia, British Journal of Radiology, 2007, 80, Special Issue 2, S128

    CrossRef

  39. You have free access to this content39
    Murat Emre, Dag Aarsland, Richard Brown, David J. Burn, Charles Duyckaerts, Yoshikino Mizuno, Gerald Anthony Broe, Jeffrey Cummings, Dennis W. Dickson, Serge Gauthier, Jennifer Goldman, Christopher Goetz, Amos Korczyn, Andrew Lees, Richard Levy, Irene Litvan, Ian McKeith, Warren Olanow, Werner Poewe, Niall Quinn, Christina Sampaio, Eduardo Tolosa, Bruno Dubois, Clinical diagnostic criteria for dementia associated with Parkinson's disease, Movement Disorders, 2007, 22, 12